Login to Your Account



Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever

By Kim Coghill


Wednesday, December 17, 2003
Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription